| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3004492 |
| Synonym(s) | Sirturo |
| Definition | A diarylquinoline antibiotic drug sold under the brand name Sirturo, used to treat infection from Mycobacterium spp., particularly multidrug-resistant tuberculosis. Bedaquiline disrupts ATP synthase by proton pump blockage, inhibiting ATP synthesis. |
| SMILES | COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12 |
| PubChem | 5388906 |
| ChEMBL | CHEMBL376488 |
| ChEBI | 72292 |
| CAS | 843663-66-1 |
| Drug Class | diarylquinoline antibiotic |
| Classification | 2 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + diarylquinoline antibiotic [Drug Class] |
| Sub-Term(s) | 4 ontology terms | Show + Mycobacterium abscessus atpE with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis Rv0678 with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis Rv2535c with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic + Mycobacterium tuberculosis atpE with mutation conferring resistance to bedaquiline confers_resistance_to_antibiotic |
| Publications | Deoghare S, et al. . Indian J Pharmacol 45(5):536-7 Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis. (PMID 24130398) |
| Curator | Description | Most Recent Edit |
|---|